Persistent Spike antigenemia is not associated with Post-COVID condition
Authors:
- Lenny CoppensLCLenny Coppens
- Orchestra Biomarker Study GroupOGOrchestra Biomarker Study Group
- Samir Kumar-SinghSKSamir Kumar-Singh
Preprint
Abstract
A bstract: Objectives: Spike antigenemia has been proposed as one of the potential mechanisms underlying post-COVID condition (PCC). Several studies addressing Spike antigenemia have measured both free and antibody-bound Spike employing 10 mM DTT to dissociate Spike–IgG complexes. Methods: Within the ORCHESTRA project, we analysed Spike and Nucleocapsid proteins in 188 participants, comprising PCC patients (n=112), non-PCC individuals (n=58) and pre-pandemic controls (n=18). For the post-pandemic cohort, 546 samples were studied from acute infection (n=99), and at 3, 6, 12, and 18 months follow-up (n=547). Impact of 10 mM DTT treatment on Spike detectability was evaluated. Correlations between Spike and proinflammatory markers were examined in both PCC and non-PCC groups. Results: DTT treatment of recombinant Spike reduced its detectability in a dose-dependent manner, with a 91.3% reduction observed at 10 mM concentration (p<0.001). In plasma, DTT treatment increased detection signals in acute COVID-19 and PCC patients (n=13) by 2.6-fold, except in an acutely infected individual with exceptionally high acute Spike levels (p<0.001). Notably, pre-pandemic plasma (n=18) also exhibited a fourfold increase in measurable signal following DTT exposure (p<0.001). Analysis of free Spike and Nucleocapsid revealed that Nucleocapsid was detectable in nearly all acute cases (n=98/99), whereas Spike was observed less frequently (15/99). Neither Spike nor Nucleocapsid antigenemia differed between PCC and controls, and no association was measured between Spike levels and PCC. Interestingly, Spike levels at 3 and 6 months correlated with inflammatory cytokines IL-6, IL-2, and IL-1β, with stronger associations observed within the PCC cohort (all p<0.05). Conclusions: Our findings indicate that DTT treatment induces Spike denaturation and artefactual neoepitope generation rather than genuine release of immune-complexed antigen. Furthermore, we demonstrate that PCC pathogenesis is less consistent with persistent Spike antigenemia. Together, these results call for harmonized biomarker methodologies for Spike antigenemia and more in-depth mechanistic studies of PCC.Keywords
This publication has 16 references indexed in Scilit:
- Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort studyClinical Microbiology and Infection, 2024
- Blood transcriptomic analyses reveal persistent SARS-CoV-2 RNA and candidate biomarkers in post-COVID-19 conditionThe Lancet Microbe, 2024
- COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients With Neurocognitive Post-COVID ComplicationsThe Journal of Infectious Diseases, 2023
- Clinical phenotypes and quality of life to define post-COVID-19 syndrome: a cluster analysis of the multinational, prospective ORCHESTRA cohorteClinicalMedicine, 2023
- Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post‐acute sequelae of COVID‐19Journal of Medical Virology, 2022
- Persistent Circulating Severe Acute Respiratory Syndrome Coronavirus 2 Spike Is Associated With Post-acute Coronavirus Disease 2019 SequelaeClinical Infectious Diseases, 2022
- Unexplained post-acute infection syndromesNature Medicine, 2022
- Disulfide Bonds Play a Critical Role in the Structure and Function of the Receptor-binding Domain of the SARS-CoV-2 Spike AntigenJournal of Molecular Biology, 2021
- Circulating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine Antigen Detected in the Plasma of mRNA-1273 Vaccine RecipientsClinical Infectious Diseases, 2021
- Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of AntibodiesCell, 2020